Scale AI Names Ex-Google Cloud Exec Francis deSouza as CEO

The permanent chief executive question at Scale AI has an answer. Axios reported that the data-labeling and AI-applications company has hired Francis deSouza as CEO, effective August 10, ending roughly a year of interim leadership under Jason Droege. deSouza was most recently chief operating officer and president of security products at Google Cloud, and before that ran the genomics company Illumina, where Reuters noted revenue grew to more than $4.5 billion and the company expanded into more than 150 countries during his tenure.

The context matters more than the biography. Scale spent 2025 absorbing the exit of founder Alexandr Wang, who left to become Meta's chief AI officer as part of a multibillion-dollar Meta investment that took a large minority stake in the company. Droege stepped in as interim CEO in June of last year, and the company has since added enterprise customers including BP and Mayo Clinic. A permanent CEO is the piece that has been missing, and picking a Google Cloud operator rather than another founder-mode technologist is a bet on the enterprise sale.

For customers, particularly the rival frontier labs that still buy Scale's training data, the signal is boring, which is probably the point. deSouza's public record is enterprise revenue growth in regulated markets, health data at Illumina and security products at Google Cloud, and Scale's growth path from here runs through the same buyers: banks, hospitals, energy majors and governments that need labeled data and AI applications wrapped in compliance.

The honest caveat is that the reporting is thin on the parts that would tell you whether this actually works. There is nothing public about deSouza's compensation, no comment on whether Meta had a say in the pick, no updated revenue number for Scale, and no read on how much of the pre-Meta customer base is still there. Droege will work with deSouza in the coming months to support the transition, which is either continuity or friction depending on which side of the memo you sit on.

If the Illumina playbook holds, sell into regulated verticals, expand geographically, monetize proprietary data, then Scale's next twelve months are less about frontier labs and more about the boring enterprise buyer who wants a vendor with a permanent name on the door.